Related Experiment Videos
HDL2 and HDL3 lipid levels in coronary artery disease
Insights
Men with coronary artery disease (CAD) show reduced high-density lipoprotein (HDL) cholesterol and phospholipid levels. These reductions were observed in both HDL2 and HDL3 subfractions, indicating a significant lipid decrease in CAD patients.
Area of Science:
- Cardiovascular Medicine
- Lipid Metabolism
Background:
- Coronary artery disease (CAD) is a major health concern.
- High-density lipoprotein (HDL) plays a crucial role in reverse cholesterol transport.
- Alterations in HDL subfractions may be linked to CAD risk.
Purpose of the Study:
- To investigate cholesterol and phospholipid levels in HDL and its subfractions (HDL2, HDL3) in men with CAD.
- To compare HDL lipid profiles between CAD patients and healthy controls.
Main Methods:
- Quantified cholesterol (C) and phospholipid (PL) in HDL, HDL2, and HDL3 fractions.
- Utilized ultracentrifugation and precipitation for subfraction separation.
- Compared measurements between 74 CAD patients and 74 matched healthy controls.
Main Results:
- CAD patients exhibited significantly lower HDL-C and HDL-PL levels compared to controls.
- Reductions were noted in both HDL2 and HDL3 subfractions, with a proportionally greater decrease in HDL2.
- HDL2-C and HDL3-PL reductions remained significant after adjusting for obesity and triglyceride levels.
- These findings were consistent across smokers and non-smokers, and in patients with or without beta-blocker medication.
Conclusions:
- Men with angiographically verified CAD have reduced levels of HDL lipids in both HDL2 and HDL3 subfractions.
- The observed decrease in HDL lipids is a significant characteristic of CAD, independent of obesity, triglycerides, smoking, or beta-blocker use.
Abstract:
The concentrations of cholesterol (C) and phospholipid (PL) levels in the high density lipoprotein (HDL) fraction and the HDL2 and HDL3 subfractions were determined in 74 men with incapacitating angina pectoris and coronary artery disease (CAD) verified by angiography. An equal number of randomly sampled healthy men matched for age, occupation and place of living constituted the control group. The HDL2 and HDL3 fractions were separated by a combination of ultracentrifugation and precipitation. The levels of HDL-C and HDL-PL were reduced in the CAD patients. The reduction of HDL lipids was attributed to both the HDL2 and HDL3 fractions. Proportionally there was a greater reduction of C and PL in HDL2 than in HDL3. The decrease of HDL2-C and HDL3-PL were significant also after allowance for the influences of obesity and triglyceride level. The reductions of HDL2 and HDL3 were significant as well in smoking as in nonsmoking CAD patients and both in patients with and without beta-adrenoceptor blocking drugs.